Chaoju Eye Care Holdings Ltd.(HK:2219)
HK$2.39-0.02 (-1.04%)
HK:2219
Chaoju Eye Care Holdings Ltd. financials statements
HK$2.39
At close:-0.02 (-1.04%)
Want to see HK:2219 full AI Analyst Report?
Chaoju Eye Care Holdings Ltd. (2219) Ratios
2 Followers
Chaoju Eye Care Holdings Ltd. Ratios
HK:2219's free cash flow for Q2 2026 was ¥100.74M. For the 2026 fiscal year, HK:2219's free cash flow was decreased by ¥-73.90M and operating cash flow was ¥174.64M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.37 | 5.03 | 5.05 | 7.41 | 8.63 |
| Quick Ratio | 4.26 | 4.92 | 4.90 | 7.20 | 8.47 |
| Cash Ratio | 1.37 | 2.30 | 1.35 | 3.86 | 5.67 |
| Solvency Ratio | 0.54 | 0.51 | 0.65 | 0.57 | 0.65 |
| Operating Cash Flow Ratio | 0.90 | 1.04 | 1.09 | 1.12 | 1.12 |
| Short-Term Operating Cash Flow Coverage | 76.19 | 50.10 | 52.09 | 22.76 | 45.15 |
| Net Current Asset Value | ¥ 1.03B | ¥ 1.15B | ¥ 1.19B | ¥ 1.39B | ¥ 1.54B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 |
| Debt-to-Equity Ratio | 0.10 | 0.09 | 0.09 | 0.09 | 0.08 |
| Debt-to-Capital Ratio | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.26 | 1.24 | 1.24 | 1.20 | 1.19 |
| Debt Service Coverage Ratio | 18.69 | 14.60 | 18.39 | 8.86 | 15.67 |
| Interest Coverage Ratio | 19.81 | 23.19 | 24.82 | 17.82 | 22.78 |
| Debt to Market Cap | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.36 | 0.33 | 0.31 | 0.29 | 0.30 |
| Net Debt to EBITDA | -0.71 | -1.68 | -0.60 | -2.79 | -3.54 |
| Profitability Margins | |||||
| Gross Profit Margin | 42.19% | 43.49% | 45.35% | 43.91% | 44.97% |
| EBIT Margin | 17.79% | 17.58% | 22.74% | 21.41% | 22.16% |
| EBITDA Margin | 28.69% | 23.86% | 31.75% | 27.06% | 30.53% |
| Operating Profit Margin | 17.79% | 17.58% | 22.14% | 21.41% | 24.07% |
| Pretax Profit Margin | 18.83% | 18.69% | 21.85% | 24.15% | 21.10% |
| Net Profit Margin | 13.49% | 13.88% | 16.72% | 18.96% | 16.21% |
| Continuous Operations Profit Margin | 13.04% | 13.25% | 16.12% | 18.50% | 15.80% |
| Net Income Per EBT | 71.63% | 74.25% | 76.50% | 78.51% | 76.81% |
| EBT Per EBIT | 105.80% | 106.33% | 98.67% | 112.80% | 87.68% |
| Return on Assets (ROA) | 6.07% | 6.77% | 7.83% | 6.89% | 6.45% |
| Return on Equity (ROE) | 7.63% | 8.42% | 9.70% | 8.26% | 7.68% |
| Return on Capital Employed (ROCE) | 9.15% | 9.72% | 11.75% | 8.55% | 10.51% |
| Return on Invested Capital (ROIC) | 6.25% | 6.78% | 8.51% | 6.42% | 7.71% |
| Return on Tangible Assets | 6.74% | 7.71% | 8.98% | 7.46% | 6.67% |
| Earnings Yield | 10.66% | 10.46% | 8.41% | 7.12% | 4.98% |
| Efficiency Ratios | |||||
| Receivables Turnover | 19.58 | 18.88 | 10.87 | 12.14 | 13.01 |
| Payables Turnover | 13.92 | 14.81 | 13.52 | 12.61 | 14.92 |
| Inventory Turnover | 18.70 | 19.70 | 14.64 | 10.60 | 15.73 |
| Fixed Asset Turnover | 1.65 | 2.22 | 2.31 | 1.67 | 1.98 |
| Asset Turnover | 0.45 | 0.49 | 0.47 | 0.36 | 0.40 |
| Working Capital Turnover Ratio | 1.03 | 1.02 | 0.93 | 0.61 | 0.98 |
| Cash Conversion Cycle | 11.93 | 13.22 | 31.49 | 35.59 | 26.78 |
| Days of Sales Outstanding | 18.64 | 19.33 | 33.56 | 30.07 | 28.05 |
| Days of Inventory Outstanding | 19.52 | 18.53 | 24.93 | 34.45 | 23.20 |
| Days of Payables Outstanding | 26.23 | 24.64 | 27.00 | 28.94 | 24.46 |
| Operating Cycle | 38.16 | 37.86 | 58.49 | 64.52 | 51.25 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.49 | 0.51 | 0.54 | 0.39 | 0.40 |
| Free Cash Flow Per Share | 0.16 | 0.51 | 0.41 | 0.21 | 0.30 |
| Dividend Paid and CapEx Coverage Ratio | 1.12 | 1.06 | 1.90 | 1.46 | 1.44 |
| Capital Expenditure Coverage Ratio | 1.50 | 5.50 | 4.30 | 2.19 | 4.14 |
| Operating Cash Flow Coverage Ratio | 1.43 | 1.63 | 1.86 | 1.39 | 1.40 |
| Operating Cash Flow to Sales Ratio | 0.25 | 0.25 | 0.27 | 0.28 | 0.25 |
| Free Cash Flow Yield | 6.54% | 19.00% | 10.50% | 5.62% | 5.82% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 9.50 | 9.56 | 11.89 | 14.05 | 20.09 |
| Price-to-Sales (P/S) Ratio | 1.27 | 1.33 | 1.99 | 2.67 | 3.26 |
| Price-to-Book (P/B) Ratio | 0.72 | 0.81 | 1.15 | 1.16 | 1.54 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 15.29 | 5.26 | 9.52 | 17.79 | 17.18 |
| Price-to-Operating Cash Flow Ratio | 5.07 | 5.26 | 7.31 | 9.65 | 13.03 |
| Price-to-Earnings Growth (PEG) Ratio | -1.33 | -0.63 | 0.54 | 3.65 | 0.45 |
| Enterprise Value Multiple | 3.70 | 3.88 | 5.66 | 7.06 | 7.13 |
| Enterprise Value | 1.44B | 1.30B | 2.46B | 1.89B | 2.17B |
| EV to EBITDA | 3.70 | 3.88 | 5.66 | 7.06 | 7.13 |
| EV to Sales | 1.06 | 0.93 | 1.80 | 1.91 | 2.18 |
| EV to Free Cash Flow | 12.81 | 3.67 | 8.60 | 12.75 | 11.48 |
| EV to Operating Cash Flow | 4.25 | 3.67 | 6.60 | 6.91 | 8.71 |
| Tangible Book Value Per Share | 3.03 | 2.83 | 2.88 | 2.96 | 3.28 |
| Shareholders’ Equity Per Share | 3.45 | 3.32 | 3.39 | 3.22 | 3.37 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.31 | 0.29 | 0.26 | 0.23 | 0.25 |
| Revenue Per Share | 1.95 | 2.02 | 1.97 | 1.40 | 1.60 |
| Net Income Per Share | 0.26 | 0.28 | 0.33 | 0.27 | 0.26 |
| Tax Burden | 0.72 | 0.74 | 0.76 | 0.79 | 0.77 |
| Interest Burden | 1.06 | 1.06 | 0.96 | 1.13 | 0.95 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.24 | 0.26 | 0.16 | 0.16 | 0.18 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
| Income Quality | 1.33 | 1.82 | 1.25 | 1.14 | 1.18 |
Currency in CNY
